HEALTHCARE PR: Direct to the consumer
27 Sep 2002 | by NICK PURDOM
After a year-long debate, Nick Purdom examines the implications of the EC review on DTC and finds that while reform is necessary, critics contend the proposals are inadequate.
Drug firms are boosting their reputations by preferential pricing, writes Mary Cowlett.
After a year-long debate, Nick Purdom examines the implications of the EC review on DTC and finds that while reform is necessary, critics contend the proposals are inadequate.
Nick Purdom reports on one of the few mature direct to consumer healthcare PR markets....and services,' explains Johnstone. The DTC debate continues while healthcare PR practitioners in the ...
developments in healthcare PR: 'The benefit of PR, beyond primary healthcare and opinion-former activities ...
brand managers don't always understand what healthcare PR has to offer, remains in some circles ...
senior people who saw this as an opportunity to move on to other things. TOP 25 HEALTHCARE PR ...
senior people who saw this as an opportunity to move on to other things. TOP 25 HEALTHCARE PR ...
and communications Fiona Tigar, who has a background in consumer and pharmaceutical and healthcare ...
healthcare PR, is running the first DTC campaign at the company since it merged a year ago. We have a ...
Client: Department of Health